Compare Novartis with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs DR. DATSONS LABS - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS DR. DATSONS LABS NOVARTIS/
DR. DATSONS LABS
 
P/E (TTM) x 562.8 -10.9 - View Chart
P/BV x 31.6 0.2 19,431.2% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 NOVARTIS   DR. DATSONS LABS
EQUITY SHARE DATA
    NOVARTIS
Mar-19
DR. DATSONS LABS
Mar-14
NOVARTIS/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs980126 780.3%   
Low Rs60031 1,942.4%   
Sales per share (Unadj.) Rs198.7133.0 149.4%  
Earnings per share (Unadj.) Rs21.00.2 13,830.1%  
Cash flow per share (Unadj.) Rs22.36.6 336.8%  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs307.5128.8 238.8%  
Shares outstanding (eoy) m24.6931.66 78.0%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x4.00.6 675.7%   
Avg P/E ratio x37.7516.1 7.3%  
P/CF ratio (eoy) x35.511.8 299.8%  
Price / Book Value ratio x2.60.6 422.9%  
Dividend payout %47.70-   
Avg Mkt Cap Rs m19,5082,477 787.4%   
No. of employees `0000.6NA-   
Total wages/salary Rs m1,17156 2,091.3%   
Avg. sales/employee Rs Th8,445.4NM-  
Avg. wages/employee Rs Th2,015.7NM-  
Avg. net profit/employee Rs Th891.0NM-  
INCOME DATA
Net Sales Rs m4,9074,211 116.5%  
Other income Rs m78379 994.4%   
Total revenues Rs m5,6894,289 132.6%   
Gross profit Rs m123569 21.6%  
Depreciation Rs m32204 15.6%   
Interest Rs m16430 3.7%   
Profit before tax Rs m85813 6,753.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3406 5,573.8%   
Profit after tax Rs m5185 10,785.4%  
Gross profit margin %2.513.5 18.5%  
Effective tax rate %39.648.0 82.5%   
Net profit margin %10.60.1 9,254.9%  
BALANCE SHEET DATA
Current assets Rs m8,0556,852 117.6%   
Current liabilities Rs m1,8506,711 27.6%   
Net working cap to sales %126.43.3 3,775.9%  
Current ratio x4.41.0 426.4%  
Inventory Days Days45161 28.0%  
Debtors Days Days34318 10.6%  
Net fixed assets Rs m1503,673 4.1%   
Share capital Rs m123317 39.0%   
"Free" reserves Rs m7,4693,761 198.6%   
Net worth Rs m7,5924,078 186.2%   
Long term debt Rs m01,671 0.0%   
Total assets Rs m9,82412,633 77.8%  
Interest coverage x54.91.0 5,336.8%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.50.3 149.8%   
Return on assets %5.43.4 157.7%  
Return on equity %6.80.1 5,792.7%  
Return on capital %11.57.7 150.0%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m58964 6.0%   
Fx outflow Rs m1,326607 218.5%   
Net fx Rs m-1,269357 -355.5%   
CASH FLOW
From Operations Rs m-1,9431,345 -144.5%  
From Investments Rs m2,742-2,256 -121.6%  
From Financial Activity Rs m-298-1,200 24.9%  
Net Cashflow Rs m501-2,111 -23.8%  

Share Holding

Indian Promoters % 0.0 4.5 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 0.0 -  
FIIs % 1.6 1.4 118.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 94.1 22.8%  
Shareholders   41,647 20,807 200.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   GSK PHARMA  ASTRAZENECA PHARMA  DIVIS LABORATORIES  IPCA LABS  NATCO PHARMA  

Compare NOVARTIS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Economic Growth and Stock Markets: It's Not All Gloom and Doom(Podcast)

In addition to the usual stock market updates of the week, I talk about how RBI's monetary policy decision and slowing economy impacts you and your portfolio of stocks.

Related Views on News

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (2QFY19); Net Profit Down 64.1% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, NOVARTIS has posted a net profit of Rs 94 m (down 64.1% YoY). Sales on the other hand came in at Rs 1 bn (down 36.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY19); Net Profit Up 42.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, NOVARTIS has posted a net profit of Rs 100 m (up 42.2% YoY). Sales on the other hand came in at Rs 1 bn (up 20.3% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Could this Smallcap Be the Next Page Industries?(Profit Hunter)

Nov 27, 2019

A single stock - Coca Cola, made Buffett billions. Here's your chance to break into the crorepati club with a single smallcap stock investment.

How We Made 12.68% in One Overnight Trade(The 5 Minute Wrapup)

Nov 25, 2019

This one trade had my subscribers laughing all the way to the bank.

Growth Stocks or Value Stocks... What Will Make You More Money in this Bull Market?(Profit Hunter)

Nov 28, 2019

Should you invest in growth stocks or value stocks to make strong returns in this market?

Two Trends to Look at as Sensex Crosses 41,000 Levels(Views On News)

Nov 26, 2019

The two trends that are playing out as Sensex touches new record high.

The Best Trading Strategy for Fast Profits

Nov 29, 2019

Vijay and I have decided to team up and bring you a unique offering never seen before in the Indian stock markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Dec 6, 2019 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS